NYSE: VEEVVeeva Systems Inc Stock
$228.78-3.70 (-1.59%)
Updated Dec 13, 2024
VEEV Price
$228.78
Fair Value Price
N/A
Market Cap
$37.14B
52 Week Low
$170.25
52 Week High
$258.93
P/E
55.53x
P/B
6.75x
P/S
12.74x
PEG
6.78x
Dividend Yield
N/A
Revenue
$2.66B
Earnings
$665.91M
Gross Margin
73.9%
Operating Margin
32.26%
Profit Margin
25.1%
Debt to Equity
0.17
Operating Cash Flow
$1B
Beta
1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VEEV Overview
Veeva Systems Incorporated provides cloud-based enterprise content and data management applications for managing commercial activities (sales and marketing), medical content and communications, and research and development functions to customers in the healthcare and life sciences sectors in the U.S. and internationally. Veeva was incorporated in 2007 and is headquartered in Pleasanton, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VEEV's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Value
C
Growth
C
Momentum
B
Sentiment
C
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
VEEV
Ranked#9 of 51
Ranked#9 of 51
Be the first to know about important VEEV news, forecast changes, insider trades & much more!
VEEV News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VEEV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VEEV ($228.78) is trading above its intrinsic value of $34.42, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VEEV is poor value based on its earnings relative to its share price (55.53x), compared to the US market average (30.75x)
P/E vs Market Valuation
VEEV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more VEEV due diligence checks available for Premium users.
Valuation
VEEV price to earnings (PE)
For valuing profitable companies with steady earnings
Company
55.53x
Industry
20.81x
Market
30.75x
VEEV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
VEEV is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
VEEV price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
6.75x
Industry
3.72x
VEEV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VEEV price to earnings growth (PEG)
For valuing profitable companies with growth potential
VEEV is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
VEEV's financial health
Profit margin
Revenue
$699.2M
Net Income
$185.8M
Profit Margin
26.6%
VEEV's Earnings (EBIT) of $856.94M... subscribe to Premium to read more.
Interest Coverage Financials
VEEV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.5B
Liabilities
$951.5M
Debt to equity
0.17
VEEV's short-term assets ($5.45B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VEEV's short-term assets ($5.45B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VEEV's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VEEV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$164.1M
Investing
-$298.2M
Financing
$13.0M
VEEV's operating cash flow ($1.08B)... subscribe to Premium to read more.
Debt Coverage Financials
VEEV vs Health Information Service Stocks
Veeva Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.